AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

10.160

-0.190-1.84%

Volume:60.52K

Turnover:621.46K

Market Cap:508.10M

PE:13.20

High:10.440

Open:10.350

Low:10.150

Close:10.350

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CLINUVEL PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

1999

Employees:

16

Office Location:

535 Bourke Street,Level 22,Melbourne,Victoria,Australia

Website:

http://www.clinuvel.com

Zip Code:

3000

Phone:

Fax:

61 3 9660 4909

Introduction:

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUV.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":10.16,"timestamp":1751609520000,"preClose":10.35,"halted":0,"volume":60520,"delay":0,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41318955,"shares":50009750,"eps":0.769445,"marketStatus":"Closed","change":-0.19,"latestTime":"07-04 16:12:00 AEST","open":10.35,"high":10.44,"low":10.15,"amount":621463,"amplitude":0.028019,"askPrice":10.2,"askSize":1995,"bidPrice":10.15,"bidSize":1094,"shortable":3,"etf":0,"ttmEps":0.769445,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1751846400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":10.35,"dividendRate":0.004921,"openAndCloseTimeList":[[1751587200000,1751608800000]],"volumeRatio":0.386281,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41318955,"roa":"14.22%","roe":"19.59%","lyrEps":0.7151,"volumeRatio":0.386281,"shares":50009750,"dividePrice":0.05,"high":10.44,"amplitude":0.028019,"preClose":10.35,"low":10.15,"week52Low":9.41,"pbRate":"2.34","psRate":"5.58","week52High":17.652,"institutionHeld":0,"latestPrice":10.16,"committee":-0.29168,"eps":0.769445,"divideRate":0.004921,"volume":60520,"delay":0,"ttmEps":0.769445,"open":10.35,"prevYearClose":12.06,"prevWeekClose":10.37,"prevMonthClose":10.38,"prevQuarterClose":10.38,"fiveDayClose":10.37,"twentyDayClose":10.4,"sixtyDayClose":10.16},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4909"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":0.0157},{"period":"1month","weight":0.0455},{"period":"3month","weight":-0.018},{"period":"6month","weight":-0.1368},{"period":"1year","weight":-0.3191},{"period":"ytd","weight":-0.1418}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0365},{"period":"6month","weight":0.1364},{"period":"1year","weight":0.2144},{"period":"ytd","weight":0.1412}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.037637},{"month":2,"riseRate":0.56,"avgChangeRate":0.008199},{"month":3,"riseRate":0.52,"avgChangeRate":0.012969},{"month":4,"riseRate":0.52,"avgChangeRate":0.049449},{"month":5,"riseRate":0.24,"avgChangeRate":-0.052177},{"month":6,"riseRate":0.56,"avgChangeRate":0.058039},{"month":7,"riseRate":0.625,"avgChangeRate":0.068349},{"month":8,"riseRate":0.458333,"avgChangeRate":-0.009555},{"month":9,"riseRate":0.541667,"avgChangeRate":0.022698},{"month":10,"riseRate":0.416667,"avgChangeRate":0.03678},{"month":11,"riseRate":0.5,"avgChangeRate":0.024773},{"month":12,"riseRate":0.583333,"avgChangeRate":0.070769}],"exchange":"ASX","name":"CLINUVEL PHARMACEUTICALS LTD","nameEN":"CLINUVEL PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"},{"date":"2024-08-29","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724889600000,"name":null,"time":"","dateTimestamp":1724853600000,"actualEps":null},{"date":"2024-02-22","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":"2023-08-29","type":"dividend","market":"AU","newRecordDate":"2023-09-06","defaultRemindTime":1693872000000,"name":"Clinuvel Pharmaceuticals Ltd","recordDate":"2023-09-20","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693836000000,"payDate":"2023-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}]}}